Tag: Medical Research

Kevin Hall, a top nutrition scientist who recently left the National Institutes of Health, revealed that he probably won't be making a comeback to the agency, even after NIH Director Jay Bhattacharya personally reached...

Adam Feuerstein, a seasoned writer and biotech columnist, dives into the world of drug development, business, Wall Street, and biotechnology. He wears many hats as a co-host of the weekly biotech podcast The Readout...

So, like, this dude Angus Chen, right? He's all about cancer stuff - drugs, policy, science, equity, you name it. He hopped on board with STAT in 2021 after doing health and science reporting...

Jay Bhattacharya, the nominee for the position of Director of the National Institutes of Health, faced a confirmation hearing on Wednesday that left many questions unanswered. Despite his reluctance to make concrete statements on...

In a world where the National Institutes of Health (NIH) announced drastic cuts to indirect costs, the implications for research, innovation, and healthcare are dire. These cuts threaten the very foundation of academic medicine,...

Amidst the bustling streets of Massachusetts, a looming shadow of uncertainty falls upon the biomedical research community. Elected leaders, including Senator Ed Markey, have sounded the alarm on the imminent impact of the Trump...

First In Vivo Beta-Thalassemia Trial by Chinese Biotech: A Groundbreaking Leap in Genetic MedicineIn a groundbreaking move that could revolutionize genetic medicine, Chinese biotech company YolTech Therapeutics has announced the initiation of the first...

GLP-1 Drugs Unveiled: Promises and Pitfalls RevealedIn a groundbreaking study published in Nature Medicine on Monday, clinical epidemiologist and nephrologist Ziyad Al-Aly from Washington University in St. Louis unveiled the comprehensive benefits and risks...

Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir among pharmaceutical companies, investors, and researchers alike. This critical issue...

Johnson & Johnson's Breakthrough Lung Cancer Drug Shows Promise in Boosting Survival RatesIn a groundbreaking development in the fight against non-small cell lung cancer, Johnson & Johnson has unveiled a potentially game-changing drug combination...

Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell LymphomaIn a groundbreaking showdown at the ASH 2024 conference, the biotech world witnessed an intense rivalry between Arcellx and Legend Biotech over their anti-BCMA CAR-T...

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...